A prescription drug may be imported into this state under the program only if the drug:

1. (1) meets the United States Food and Drug Administration's standards related to prescription drug safety, effectiveness, misbranding, and adulteration;
2. (2) does not violate any federal patent laws through its importation;
3. (3) is expected to generate cost savings for consumers; and

4. (4) is not:

   1. (A) listed as a controlled substance under state or federal law;
   2. (B) a biological product;
   3. (C) an infused drug;
   4. (D) an intravenously injected drug;
   5. (E) a drug that is inhaled during surgery; or
   6. (F) a parenteral drug.

Added by Acts 2023, 88th Leg., R.S., Ch. 655 (H.B. 25), Sec. 2, eff. September 1, 2023.